Skip to content

Treatment of white patches (leucoderma) by herbo-mineral gel

Pharmaceutico-therapeutic evaluation of gel prepared from Karpanpatru Taila and Shvitrahara Yoga on Shvitra (vitiligo)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/005986
Enrollment
100
Registered
2015-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having signs and symptoms of Shvitra (vitiligo). Patients having ages of 16 to 60 years. Patients with chronicity of less than 10 years. Woodâ??s lamp test positive.

Interventions

Intervention1: Gel prepared from Karpanpatru Taila: Dose: QS for local application, once in a day at morning time Duration: 8weeks Follow up: 4weeks Intervention2: Gel prepared from Shvitrahara Yoga:

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients having signs and symptoms of Shvitra (vitiligo). • Patients having Sadhya Lakshana of Shvitra. • Patients having ages of 16 to 60 years. • Patients with chronicity of less than 10 years. • Woodâ??s lamp test positive.

Exclusion criteria

Exclusion criteria: Patients having • Chronicity more than 10 years. • Serious cardiac, renal, hepatic diseases, major illness like IDDM, NIDDM, patches due to burning, chemical explosion, any other serious systemic illness. • Gravid and lactating women. • Lesions at region of Guhyanga (genital organ), Panipadatala (sole of palm and feet), Oshtha (lips), Aekanga (particular whole organ), Sarvanga (whole body). • Patches with Raktaroma (reddish hair) & Samsakta (coalescent).

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will exert a significant action on Shvitra.Timepoint: 4 weeks

Secondary

MeasureTime frame
â?¢ By providing better effect on Shvitra, the drug will effect psycho-somatic level of patient and stress condition due to disease and enhance quality of life.Timepoint: 2 monts

Countries

India

Contacts

Public ContactProf P K Prajapati

Institute for post graduate teachind and research in Ayurveda

galib14@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026